4-Phenoxyphenylboronic acid

4-Phenoxyphenylboronic acid

Intermediate for Ibrutinib. Ibrutinib (trade name: Imbruvica) is a small Bruton's tyrosine kinase (BTK) inhibitor. Ibrutinib is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenstrom's macroglobulinemia, a form of non-Hodgkin's lymphoma. Ibrutinib has been approved by the U.S Food and Drug Administration on November 19, 2013.

Specifications

Product Name:                  4-Phenoxyphenylboronic acid

Synonyms:                         N/A

CAS Number:                     51067-38-0

Molecular Weight:            214.0271

Molecular Formula:          C12H11BO3

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               OB(c1ccc(cc1)Oc1ccccc1)O

  • $69.00
  • Ex Tax: $69.00

Available Options